United States· US:73554-1111_35e89ce3-d947-47dc-971c-8450f3afe4a8
Lyfgenia
A lovotibeglogene autotemcel product containing lovotibeglogene autotemcel, registered in United States by Genetix Biotherapeutics Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LOVOTIBEGLOGENE AUTOTEMCEL
- Manufacturer
- Genetix Biotherapeutics Inc.
- Country
- United States (US)
- ATC code
- B06AX06
- ATC class
- Lovotibeglogene autotemcel
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 19, 2026
Packs & prices · 2
- ndc1173554-1111-1
- ndc1173554111111 mL in 1 BAG (73554-1111-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B06AX06
Lovotibeglogene autotemcel, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfa2a0f3-558f-41b6-b1d5-c2a8a195ed37 GET /v1/drugs/cfa2a0f3-558f-41b6-b1d5-c2a8a195ed37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "20000000",
"substance": "LOVOTIBEGLOGENE AUTOTEMCEL",
"productndc": "73554-1111",
"dosage_form": "SUSPENSION",
"dea_schedule": null,
"strength_unit": "1/20mL",
"application_number": "BLA125788",
"marketing_category": "BLA"
}See everything about lovotibeglogene autotemcel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.